glutamine has been researched along with Depressive Disorder, Major in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (23.33) | 29.6817 |
2010's | 32 (53.33) | 24.3611 |
2020's | 14 (23.33) | 2.80 |
Authors | Studies |
---|---|
Cai, H; Cao, T; Chen, Q; Jiao, S; Wang, L; Wu, X; Yang, C; Yang, D; Yang, P; Zeng, C; Zhang, S; Zhu, Z | 1 |
Barredo, J; Carpenter, LL; Fukuda, AM; Gonsalves, MA; Harris, AD; Joyce, HE; White, TL | 1 |
Barbini, B; Benedetti, F; Bravi, B; Dallaspezia, S; Melloni, EMT; Poletti, S; Zanardi, R | 1 |
Allauze, E; Chabert, J; Chassain, C; De Chazeron, I; Fossati, P; Llorca, PM; Pereira, B; Rotgé, JY; Samalin, L | 1 |
Ban, M; He, J; Kong, L; Wang, D; Xiao, Q; Yuan, F; Zhu, X | 1 |
Bi, Y; Chen, Y; He, R; Li, M; Lin, H; Lu, J; Ning, G; Wang, S; Wang, T; Wang, W; Xu, M; Xu, Y; Zhao, Z; Zheng, J; Zheng, R | 1 |
Pavlova, I; Ruda-Kucerova, J | 1 |
Boeker, H; Ernst, J; Grimm, S; Lehmann, M; Richter, A; Seifritz, E; Wade-Bohleber, L; Zoelch, N | 1 |
de Diego-Adeliño, J; Draganov, M; Portella, MJ; Puigdemont, D; Vicent-Gil, M; Vives-Gilabert, Y | 1 |
Atalay, S; Cummings, A; Ding, XQ; Frieling, H; Kahl, KG; Lanfermann, H; Maudsley, AA; Schmitz, B; Sheriff, S | 1 |
Alvarez-Vazquez, C; Gonzalez-Blanco, L; Jimenez-Trevino, L; Rodriguez-Revuelta, J; Saiz Martinez, PA | 1 |
Cheng, PZ; Duncan, NW; Hsu, TY; Lane, TJ; Lee, HC; Truong, V | 1 |
Badamasi, IM; Ibrahim, N; Lye, MS; Maulidiani, M; Shaari, K; Stanslas, J | 1 |
Aryutova, K; Kandilarova, S; Paunova, R; Stoyanov, D; Todeva-Radneva, A | 1 |
Chen, JX; Ding, XF; Jiao, HY; Li, YH; Sun, LJ; Wang, XX; Zhou, Y | 1 |
Bradley, KA; Gabbay, V; Kang, G; Mao, X; Ostrover, R; Shungu, DC | 1 |
Cowen, PJ; Emir, UE; Godlewska, BR; Masaki, C; Sharpley, AL | 1 |
Arnone, D; Cappello, F; Cleare, AJ; Gammazza, AM; Herane-Vives, A; Lythgoe, DJ; Taylor, MJ; Williams, SC; Wise, T; Young, AH | 1 |
Hara, A; Okubo, T; Osone, F; Shirayama, Y; Takahashi, M | 1 |
An, L; Banerjee, D; Evans, JW; Lally, N; Li, N; Nugent, AC; Roiser, JP; Shen, J; Snider, SL; Zarate, CA | 1 |
Forman, J; Kessing, LV; Knorr, U; Pech, J | 1 |
Chea, W; Gardner, AC; Godfrey, KEM; Kwon, S; Muthukumaraswamy, SD | 1 |
Blumberger, DM; Daskalakis, ZJ; ElSalhy, M; Graff-Guerrero, A; Horita, N; Katayama, N; Kishimoto, T; Meyer, JH; Mimura, M; Miyazaki, T; Moriguchi, S; Nakajima, S; Noda, Y; Ogyu, K; Plitman, E; Sano, Y; Takamiya, A; Tarumi, R; Tsugawa, S; Wada, M | 1 |
Colic, L; Demenescu, LR; Denzel, D; Frommer, J; Kaufmann, J; Li, M; Lison, S; Lord, AR; Martens, L; Speck, O; Vogel, M; von Düring, F; Walter, M | 1 |
Brechbühl, S; Buchmann, A; Ghisleni, C; Hasler, G; Haynes, M; Müller, ST; Tuura, R | 1 |
Álvarez, E; de Diego-Adeliño, J; Gómez-Ansón, B; López-Moruelo, O; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D; Serra-Blasco, M; Vives, Y | 1 |
Chen, LP; Dai, HY; Dai, ZZ; Wu, RH; Xu, CT | 1 |
Taylor, MJ | 1 |
Cooper, TB; Kegeles, LS; Keilp, JG; Mann, JJ; Mao, X; Milak, MS; Mulhern, ST; Ogden, RT; Oquendo, MA; Parter, AL; Proper, CJ; Rodriguez, CI; Shungu, DC; Suckow, RF | 1 |
Hamazaki, K; Hamazaki, T; Hashimoto, K; Matsuoka, Y; Nishi, D; Noguchi, H | 1 |
Banerjee, S; Dubin, MJ; Goodman, Z; Kang, G; Lapidus, KA; Liston, C; Mao, X; Shungu, DC | 1 |
Blennow, K; Bruno, D; Hashimoto, K; Marmar, CR; Nierenberg, J; Pomara, N; Zetterberg, H | 1 |
Li, Y; Maletic-Savatic, M; Sheng, J; Tang, Y; Tong, S; Wang, J; Zhang, T; Zhang, X; Zhu, Y | 1 |
Biswal, B; Colic, L; Demenescu, LR; Li, M; Li, S; Metzger, CD; Safron, A; Walter, M | 1 |
Guan, JT; Guo, XB; Li, H; Liu, CF; Ou, SM; Shen, ZW; Tan, HZ; Wang, XQ; Wen, CH; Wu, RH; Xu, CT; Zhang, J; Zhang, YN | 1 |
Cho, H; Kim, CH; Kim, DG; Kim, GT; Seo, J | 1 |
Auer, DP; Murck, H; Schmid, D; Schubert, MI; Schüssler, P; Steiger, A | 1 |
Block, W; Jessen, F; Maier, W; Metten, M; Schild, H; Träber, F; von Widdern, O; Zobel, A | 1 |
Charney, DS; Collins, KA; Kelly, C; Mao, X; Mathew, SJ; Murrough, JW; Nestadt, P; Price, RB; Shungu, DC | 1 |
Hall, GB; MacQueen, GM; Milne, A; Soreni, N; Yucel, K | 1 |
Beck, J; Boeker, H; Boesiger, P; Dydak, U; Grimm, S; Henning, A; Northoff, G; Schnepf, B; Schulte, RF; Walter, M | 1 |
Cowen, PJ; Jezzard, P; Murphy, S; Norbury, R; Rudebeck, S; Taylor, MJ | 1 |
Caetano, SC; Chen, HH; Hatch, JP; Matsuo, K; Monkul, ES; Najt, P; Nery, FG; Nicoletti, MA; Peluso, MA; Soares, JC; Stanley, JA | 1 |
Austin, MC; Miguel-Hidalgo, JJ; Rajkowska, G; Stockmeier, CA; Waltzer, R; Whittom, AA | 1 |
Cowen, PJ; Mannie, ZN; Near, J; Norbury, R; Taylor, MJ | 1 |
Anttila, S; Huuhka, M; Illi, A; Kampman, O; Lehtimäki, T; Leinonen, E; Mononen, N; Setälä-Soikkeli, E; Viikki, M | 1 |
Bird, TD; Ghetti, B; Jayadev, S; Leverenz, JB; Mastrianni, JA; Montine, TJ; Nochlin, D; Poorkaj, P; Schellenberg, GD; Steinbart, EJ | 1 |
Cowen, PJ; Mhuircheartaigh, RN; Taylor, MJ; Tiangga, ER | 1 |
Baumann, J; Drevets, WC; Ibrahim, LA; Luckenbaugh, DA; Machado-Vieira, R; Marenco, S; Salvadore, G; Shen, J; van der Veen, JW; Zarate, CA; Zhang, Y | 1 |
Garakani, A; Gorman, JM; Martinez, JM; Yehuda, R | 1 |
Owen, RT | 1 |
Berk, M; Das, P; Dean, OM; Dodd, S; Fritz, K; Malhi, GS; Tanious, M | 1 |
Arolt, V; Erfurth, A; Heindel, W; Michael, N; Ohrmann, P; Pfleiderer, B | 1 |
Banerjee, SP; Bhandari, R; Boyd, C; Ivey, J; Mirza, Y; Moore, GJ; Rose, M; Rosenberg, DR; Russell, A; Smith, JM; Tang, J | 1 |
Caetano, SC; Fonseca, M; Hatch, JP; Hunter, K; Lafer, B; Nicoletti, M; Olvera, RL; Pliszka, SR; Soares, JC; Stanley, JA | 1 |
Bain, EE; Charney, DS; Drevets, WC; Hasler, G; Neumeister, A; Shen, J; Tumonis, T; van der Veen, JW | 1 |
Banerjee, SP; Bhandari, R; Boyd, C; Easter, PC; Ivey, J; Lynch, M; Macmaster, FP; Mirza, Y; Moore, GJ; Renshaw, P; Rose, M; Rosenberg, DR; Smith, JM; Villafuerte, RA | 1 |
Ajilore, O; Binesh, N; Darwin, C; Haroon, E; Kumar, A; Kumaran, S; Miller, J; Mintz, J; Thomas, MA | 1 |
Drevets, WC; Hasler, G; Meyers, N; Shen, J; Tumonis, T; van der Veen, JW | 1 |
Auer, DP; Holsboer, F; Kraft, E; Lipinski, B; Pütz, B; Schill, J | 1 |
10 review(s) available for glutamine and Depressive Disorder, Major
Article | Year |
---|---|
Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review.
Topics: Depression; Depressive Disorder, Major; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Neocortex; Prefrontal Cortex; Transcranial Magnetic Stimulation; Treatment Outcome | 2022 |
Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies.
Topics: Aspartic Acid; Bipolar Disorder; Depressive Disorder, Major; Glutamic Acid; Glutamine; Humans; Proton Magnetic Resonance Spectroscopy | 2022 |
Brain metabolic derangements examined using
Topics: Animals; Aspartic Acid; Brain; Depression; Depressive Disorder, Major; Glutamic Acid; Glutamine; Proton Magnetic Resonance Spectroscopy; Rodentia | 2023 |
Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis.
Topics: Depressive Disorder, Major; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging | 2021 |
The Translational Potential of Non-coding RNAs and Multimodal MRI Data Sets as Diagnostic and Differential Diagnostic Biomarkers for Mood Disorders.
Topics: Biomarkers; Bipolar Disorder; Brain; Depressive Disorder, Major; Gene Expression Regulation; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; MicroRNAs; Mood Disorders; RNA, Untranslated | 2021 |
Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Young Adult | 2018 |
Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.
Topics: Depressive Disorder, Major; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Prefrontal Cortex | 2018 |
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Depression; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Synaptic Transmission | 2019 |
Could glutamate spectroscopy differentiate bipolar depression from unipolar?
Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Diagnosis, Differential; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity | 2014 |
Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; Glutamine; Humans; Ketamine; Memantine; Riluzole; Treatment Outcome | 2012 |
7 trial(s) available for glutamine and Depressive Disorder, Major
Article | Year |
---|---|
7T
Topics: Adult; Antidepressive Agents; Brain; Cross-Over Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Male; Proton Magnetic Resonance Spectroscopy | 2018 |
Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.
Topics: Adolescent; Adult; Antidepressive Agents; Aspartic Acid; Cerebellum; Choline; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2014 |
Glutamatergic system abnormalities in posttraumatic stress disorder.
Topics: Adult; Biomarkers; Case-Control Studies; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Stress Disorders, Post-Traumatic | 2015 |
The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Choline; Creatine; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Prefrontal Cortex; Psychiatric Status Rating Scales; Sex Factors; Sleep Deprivation; Treatment Outcome | 2009 |
Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers.
Topics: Adult; Citalopram; Depressive Disorder, Major; Female; Frontal Lobe; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Software; Young Adult | 2010 |
Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
Topics: Acetylcysteine; Aspartic Acid; Depressive Disorder, Major; Double-Blind Method; Female; Free Radical Scavengers; Functional Neuroimaging; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Oxidative Stress | 2013 |
Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients.
Topics: Adolescent; Child; Choline; Depressive Disorder, Major; Female; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Prefrontal Cortex; Protons | 2005 |
43 other study(ies) available for glutamine and Depressive Disorder, Major
Article | Year |
---|---|
Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Biomarkers; Depressive Disorder, Major; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Serotonin; Tryptophan; Vanilmandelic Acid | 2022 |
Antidepressant chronotherapeutics normalizes prefrontal
Topics: Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Drug Chronotherapy; Glutamic Acid; Glutamine; Humans; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy | 2022 |
Regional metabolic heterogeneity in anterior cingulate cortex in major depressive disorder: A multi-voxel
Topics: Aspartic Acid; Depressive Disorder, Major; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Proton Magnetic Resonance Spectroscopy; Young Adult | 2022 |
Causal Association Between Obesity, Circulating Glutamine Levels, and Depression: A Mendelian Randomization Study.
Topics: Anhedonia; Body Mass Index; Causality; Depression; Depressive Disorder, Major; Genome-Wide Association Study; Glutamine; Humans; Mendelian Randomization Analysis; Obesity; Polymorphism, Single Nucleotide | 2023 |
Effects of Psychotherapy on Glutamatergic Neurotransmission.
Topics: Depressive Disorder, Major; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Psychotherapy, Psychodynamic; Synaptic Transmission | 2023 |
Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR spectroscopic study.
Topics: Depression; Depressive Disorder, Major; Follow-Up Studies; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy | 2020 |
Altered neurometabolism in major depressive disorder: A whole brain
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Depressive Disorder, Major; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Young Adult | 2020 |
Glutamine and New Pharmacological Targets to Treat Suicidal Ideation.
Topics: Bipolar Disorder; Depressive Disorder, Major; Glutamine; Humans; Suicidal Ideation; Suicide | 2020 |
A Preliminary Nuclear Magnetic Resonance Metabolomics Study Identifies Metabolites that Could Serve as Diagnostic Markers of Major Depressive Disorder.
Topics: Acetone; Alanine; Biomarkers; Choline; Creatinine; Depressive Disorder, Major; Fatty Acids; Glutamine; Humans; Lactates; Magnetic Resonance Spectroscopy; Metabolomics; Valine | 2022 |
Involvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed mice.
Topics: Animals; Antidepressive Agents; China; Depressive Disorder, Major; Drugs, Chinese Herbal; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; Glutamine; Humans; Male; Mice | 2017 |
Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression.
Topics: Adolescent; Anhedonia; Brain; Child; Depression; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Male; Proton Magnetic Resonance Spectroscopy; Severity of Illness Index; Young Adult | 2017 |
Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla.
Topics: Adolescent; Adult; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Male; Middle Aged; Occipital Lobe; Proton Magnetic Resonance Spectroscopy; Putamen; Young Adult | 2018 |
Glutamatergic hypofunction in medication-free major depression: Secondary effects of affective diagnosis and relationship to peripheral glutaminase.
Topics: Adult; Case-Control Studies; Depressive Disorder, Major; Female; Glutamic Acid; Glutaminase; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Young Adult | 2018 |
Myo-inositol, Glutamate, and Glutamine in the Prefrontal Cortex, Hippocampus, and Amygdala in Major Depression.
Topics: Adult; Amygdala; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Temporal Lobe | 2017 |
Rostral Anterior Cingulate Glutamine/Glutamate Disbalance in Major Depressive Disorder Depends on Symptom Severity.
Topics: Adult; Anhedonia; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Severity of Illness Index | 2019 |
Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy.
Topics: Adult; Anxiety Disorders; Cross-Sectional Studies; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Male; Neuroticism; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Young Adult | 2019 |
Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.
Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Cost of Illness; Cross-Sectional Studies; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2013 |
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.
Topics: Adult; Amino Acids; Antidepressive Agents; Brain; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Imaging; Male; Middle Aged; Neurotransmitter Agents; Pilot Projects; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Tritium | 2016 |
Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Treatment Outcome; Young Adult | 2016 |
Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
Topics: Aged; Aging; Chromatography, High Pressure Liquid; Cognition; Depressive Disorder, Major; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Male; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2016 |
Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Neurons; Prefrontal Cortex; Psychiatric Status Rating Scales | 2016 |
A spectroscopic approach toward depression diagnosis: local metabolism meets functional connectivity.
Topics: Adult; Cerebral Cortex; Connectome; Creatine; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2017 |
Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders.
Topics: Adult; Aspartic Acid; Biomarkers; Bipolar Disorder; Case-Control Studies; Choline; Creatine; Depressive Disorder, Major; Glutamine; Gray Matter; Humans; Inositol; Organ Specificity | 2016 |
Glutamatergic stimulation of the left dentate gyrus abolishes depressive-like behaviors in a rat learned helplessness paradigm.
Topics: Adaptation, Psychological; Animals; Dentate Gyrus; Depressive Disorder, Major; Glutamine; Helplessness, Learned; Rats; Stress, Psychological | 2017 |
Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Statistics, Nonparametric; Young Adult | 2009 |
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.
Topics: Adult; Brain; Case-Control Studies; Depressive Disorder, Major; Drug Resistance; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurotransmitter Agents; Occipital Lobe | 2009 |
Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study.
Topics: Adult; Analysis of Variance; Aspartic Acid; Choline; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Organ Size; Protons; Recurrence | 2009 |
The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.
Topics: Adult; Arousal; Aspartic Acid; Blood Glucose; Corpus Callosum; Depressive Disorder, Major; Dominance, Cerebral; Emotions; Energy Metabolism; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurons; Oxygen Consumption; Synaptic Transmission | 2009 |
Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1)H spectroscopy study.
Topics: Adolescent; Adult; Aspartic Acid; Brain Mapping; Case-Control Studies; Chi-Square Distribution; Creatine; Depressive Disorder, Major; Female; Functional Laterality; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphocreatine; Prefrontal Cortex; Protons; Psychiatric Status Rating Scales; Young Adult | 2009 |
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.
Topics: Adult; Aged; Alcoholism; Astrocytes; Comorbidity; Depressive Disorder, Major; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Female; Frontal Lobe; Glial Fibrillary Acidic Protein; Glutamate Plasma Membrane Transport Proteins; Glutamate-Ammonia Ligase; Glutamine; Humans; Male; Middle Aged; Prefrontal Cortex; Reference Values; Synaptic Transmission | 2010 |
Elevated cortical glutamate in young people at increased familial risk of depression.
Topics: Adolescent; Cerebral Cortex; Depression; Depressive Disorder; Depressive Disorder, Major; Family; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Occipital Lobe; Risk Factors; Young Adult | 2011 |
P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.
Topics: Adult; Aged; Arginine; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Glutamine; Histidine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Purinergic P2X7; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Tyrosine | 2011 |
Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.
Topics: Adult; Aged; Alzheimer Disease; Codon, Nonsense; Depressive Disorder, Major; Female; Glutamine; Humans; Memory Disorders; Memory, Short-Term; Middle Aged; Neurofibrillary Tangles; Neuropsychological Tests; Phenotype; Prion Diseases; Prion Proteins; Prions; tau Proteins; Tyrosine | 2011 |
Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study.
Topics: Adult; Cerebral Cortex; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Protons; Young Adult | 2012 |
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
Topics: Adult; Cerebral Cortex; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurotransmitter Agents; Predictive Value of Tests; Psychiatric Status Rating Scales; Retrospective Studies | 2012 |
Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.
Topics: Adult; Antidepressive Agents; Case-Control Studies; Corticotropin-Releasing Hormone; Cyclohexanols; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression.
Topics: Aged; Brain Mapping; Depressive Disorder, Major; Dominance, Cerebral; Electroconvulsive Therapy; Energy Metabolism; Female; Glutamic Acid; Glutamine; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Reference Values | 2003 |
Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
Topics: Adolescent; Aspartic Acid; Child; Choline; Creatine; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Personality Assessment; Phosphocreatine; Reference Values; Synaptic Transmission | 2004 |
Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Prefrontal Cortex; Psychiatric Status Rating Scales | 2005 |
Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.
Topics: Adolescent; Brain Chemistry; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male | 2005 |
Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Chemistry; Choline; Creatine; Depressive Disorder, Major; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Psychiatric Status Rating Scales | 2007 |
Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
Topics: Adult; Ambulatory Care; Cell Count; Cross-Sectional Studies; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroglia; Prefrontal Cortex | 2007 |
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
Topics: Adult; Aged; Aspartic Acid; Choline; Creatine; Depressive Disorder, Major; Female; Frontal Lobe; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myo-Inositol-1-Phosphate Synthase; Severity of Illness Index | 2000 |